Infectious disease diagnostics market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Infectious diseases are diseases caused by microscopic organisms including bacteria, viruses, parasites, and fungi. The organisms enter the body, multiply and cause symptoms ranging from mild to severe, including death. According to WHO, At least 169 severe hepatitis cases have been identified in children in an outbreak that involves 12 countries. Further in July 2022, WHO declared monkeypox a global health emergency. Climate change, rapid urbanization, globalnisation, and the rising burden of infectious diseases and hospital acquired infections are primary factors driving the market growth of the infectious disease diagnostics market. The shift from centralized laboratories towards decentarlised point of care testing due to delay in results, high cost of tests, and late disease diagnosis is also an important factor anticipated to propel the demand for infectious disease diagnostics during the forecast period. Also, Several government-funded programs all over the globe are increasingly providing free screening and tests in order to increase awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to drive the market growth in forecast period. For instance, in August 2022, the Australian Government funded $5.2 million to strengthen laboratory capacity for testing and diagnosis of COVID-19, HIV, malaria and tuberculosis in the Indo-Pacific region.
The global infectious disease diagnostics market is segmented based on the product & solution, technology, disease type, and end-user. Based on the product & solution, the market is segmented into consumables, instruments, and software & services. Based on the technology, the market is sub-segmented into the immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. Based on the disease type, the market is sub-segmented into the hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), Human, papillomavirus (HPV), tuberculosis (TB), influenza and other diseases. Based on the End-User, the market is sub-segmented into the hospital/clinical laboratories, reference laboratories, academics/research institutes, and others. Among product & solution, the consumables sub-segment is anticipated to hold the dominant share in the market.
To Request a Sample of our Report on Infectious Disease Diagnostics Market: https://www.omrglobal.com/request-sample/infectious-disease-diagnostics-market
Infectious Disease Diagnostics Market Segmentation
By Product & Solution
- Consumables
- Instruments
- Software & Services
By Technology
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- DNA Sequencing and Next-Generation Sequencing (NGS)
- DNA Microarray Technology
- Other technologies
- (Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification)
By Disease Type
- Hepatitis
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
- Tuberculosis (TB)
- Influenza
- Other Diseases (measles, smallpox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough)
By End-User
- Hospital/Clinical Laboratories
- Reference Laboratories
- Academics/Research Institutes
- Others
A full Report of Infectious Disease Diagnostics Market is Available @ https://www.omrglobal.com/industry-reports/infectious-disease-diagnostics-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Becton, Dickinson and Company
- bioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- Chembio Diagnostic Systems
- Danaher Corp.
- DiaSorin S.p.A.
- ELITech Group
- Genetic Signatures Ltd.
- Grifols S.A.
- Hologic, Inc.
- Meridian Bioscience Inc.
- Meril Life Sciences Pvt. Ltd.
- Clinical Diagnostics Holdings plc
- QIAGEN N.V.
- Quidel Corp.
- Seegene, Inc.
- Sysmex Corp.
- Trinity Biotech Plc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/infectious-disease-diagnostics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404